Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Mareike Berlak
, Elizabeth Tucker
, Mathurin Dorel
, Annika Winkler
, Aleixandria McGearey
, Elias Rodriguez-Fos
, Barbara Martins da Costa
, Karen Barker
, Elicia Fyle
, Elizabeth Calton
, Selma Eising
, Kim Ober
, Deborah Hughes
, Eleni Koutroumanidou
, Paul Carter
, Reda Stankunaite
, Paula Proszek
, Neha Jain
, Carolina Rosswog
, Heathcliff Dorado-Garcia
Jan Jasper Molenaar, Mike Hubank, Giuseppe Barone, John Anderson, Peter Lang, Hedwig Elisabeth Deubzer, Annette Künkele, Matthias Fischer, Angelika Eggert, Charlotte Kloft, Anton George Henssen, Michael Boettcher, Falk Hertwig, Nils Blüthgen, Louis Chesler, Johannes Hubertus Schulte
Duik in de onderzoeksthema's van 'Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells'. Samen vormen ze een unieke vingerafdruk.